From Singapore lab to No 1 US seller: P&G’s Olay serum a breakout success for Republic’s innovation push
The ‘super serum’ by Procter & Gamble is just one success story to come out of its innovation centre in Biopolis. In the first of an occasional series, The Business Times takes a closer look at the innovation scene in Singapore.
Add BT as a preferred source
AFTER Procter & Gamble (P&G) launched the Olay Super Serum in the United States in 2023, the product shot to pole position among serums there. A bottle of this, combining five benefits of serums into one potion, was being sold every minute.
It was flying off the shelves, but what was less well-known about it was that it was a product of the P&G Singapore Innovation Centre (SgIC) located in Biopolis, Singapore’s research and development (R&D) hub for biomedical science.
The SgIC is the consumer goods giant’s largest beauty innovation hub in Asia. The 32,000 square metre facility handles consumer understanding, formulation, advanced analytical capabilities, data science and modelling, along with state-of-the-art packaging design.
TRENDING NOW
Johor property old hand KSL readies family handover amid market boom
Seatrium eyes S$28 billion in project opportunities amid global race for energy security
China targets offshore billions in biggest crackdown in decades
Trek 2000 shares jump 41.5% after Osim founder Ron Sim drops claims, sells 7.3% stake to Azure Capital
